Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 9/20 | 0.73 |
| ▸ | LATS1 | O95835 | 1/20 | 0.46 |
| ▸ | RIPK3 | Q9Y572 | 6/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.39 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1744576 | 0.88 | CSNK1E (0.92) | CSNK1ELATS1RIPK3 | |
| SCHEMBL1745908 | 0.88 | CSNK1E (0.63) | CSNK1ELATS1RIPK3PRKCQEIF2AK4 | |
| SCHEMBL3107141 | 0.85 | CSNK1E (1.00) | CSNK1ELATS1RIPK3 | |
| SCHEMBL1746568 | 0.83 | CSNK1E (0.77) | CSNK1ELATS1RIPK3 | |
| SCHEMBL3110570 | 0.83 | CSNK1E (1.00) | CSNK1ELATS1RIPK3 | |
| SCHEMBL1744357 | 0.82 | CSNK1E (0.55) | CSNK1ELATS1PRKCQEIF2AK4PIM1 | |
| SCHEMBL3116817 | 0.81 | CSNK1E (1.00) | CSNK1ELATS1RIPK3 | |
| SCHEMBL3105787 | 0.80 | CSNK1E (0.81) | CSNK1ELATS1RIPK3 | |
| SCHEMBL1744530 | 0.80 | CSNK1E (0.84) | CSNK1ELATS1RIPK3 | |
| SCHEMBL3111989 | 0.80 | CSNK1E (1.00) | CSNK1ELATS1RIPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385946-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND TUERAPEUTIC APPLICATION THEREOF | SANOFI (FR) | 2011-11-16 | — | — | EP | disclosed |
| US-8040450-B2 | Liquid crystal electro-optic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| WO-2010070238-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010070238-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2010-06-24 | — | — | WO | disclosed |